VISTAGEN THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2017 | -1,665.4% | -1,665.4% | -276.3% |
| FY2018 | -207.4% | -207.4% | -127.2% |
| FY2019 | -347.5% | -347.5% | -175.5% |
| FY2020 | 362.6% | 362.6% | -359.9% |
| FY2021 | -19.5% | -19.5% | -16.6% |
| FY2022 | -73.8% | -73.8% | -64.0% |
| FY2023 | -490.5% | -490.5% | -280.9% |
| FY2024 | -25.7% | -25.7% | -23.7% |
| FY2025 | -73.0% | -73.0% | -61.0% |
| FY2026 | -196.2% | -196.2% | -143.5% |